The fields of bone marrow transplantation and malignant hematology have been transformed in recent years. In this Grand Rounds, we will explore novel therapies, such as the use of immune effector cells in hematological malignancies. We will discuss the rationale behind these treatments and practical clinical pearls in the management of patients with hematologic malignancies.
Speakers:
Babis Andreadis, MD, MS, is a professor in the Division of Hematology and Oncology at UCSF Health and director of the Baszucki Lymphoma Therapeutic Initiative for the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include drug toxicity and genetic and patient factors behind differential responses to therapy.
Ajai Chari, MD, is also a professor in the Division of Hematology and Oncology at UCSF Health. He is also the director of the Multiple Myeloma Program. His research interests include the development of novel chemotherapy regimens, including Phase 1 and 2 national and international trials.
Note: Closed captions will be available within 48-72 hours after posting.
Program
Bob Wachter: Introduction
2:25-24:56 - Babis Andreadis, MD, MS, professor in the Division of Hematology and Oncology at UCSF Health
24:59-39:05 - Ajai Chari, MD, professor in the Division of Hematology and Oncology at UCSF Health
39:09-59:46 - Q&A
See previous Medical Grand Rounds:
March 21: From Pipettes to Populations: Building an Integrated Program for ID Research and Education
• From Pipettes to Popul...
March 14: 31st Annual Alice Hamilton Lecture: Dust in the Lungs, an Ancient Disease Still with Us
• 31st Annual Alice Hami...
March 7: Hollander Rounds: Clinical Problem Solving with Monica Fung
• Hollander Rounds: Clin...
February 29: Lifestyle and Atrial Fibrillation: Adventures in Clinical Research
• Lifestyle and Atrial F...
See all UCSF grand rounds, which have been viewed over 3M times, at • UCSF Department of Med... .